JP2018535953A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018535953A5 JP2018535953A5 JP2018519727A JP2018519727A JP2018535953A5 JP 2018535953 A5 JP2018535953 A5 JP 2018535953A5 JP 2018519727 A JP2018519727 A JP 2018519727A JP 2018519727 A JP2018519727 A JP 2018519727A JP 2018535953 A5 JP2018535953 A5 JP 2018535953A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- age
- subject
- sequence identity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562241007P | 2015-10-13 | 2015-10-13 | |
| US62/241,007 | 2015-10-13 | ||
| US14/974,561 US10358502B2 (en) | 2014-12-18 | 2015-12-18 | Product and method for treating sarcopenia |
| US14/974,561 | 2015-12-18 | ||
| PCT/US2016/034880 WO2017065837A1 (en) | 2015-10-13 | 2016-05-27 | Anti-age antibodies and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018535953A JP2018535953A (ja) | 2018-12-06 |
| JP2018535953A5 true JP2018535953A5 (https=) | 2019-06-27 |
Family
ID=58518256
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018519727A Pending JP2018535953A (ja) | 2015-10-13 | 2016-05-27 | 抗ａｇｅ抗体およびその使用方法 |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP3362483A1 (https=) |
| JP (1) | JP2018535953A (https=) |
| KR (1) | KR20180056689A (https=) |
| CN (1) | CN108431044A (https=) |
| AU (1) | AU2016336959A1 (https=) |
| BR (1) | BR112018007422A2 (https=) |
| CA (1) | CA3000815C (https=) |
| IL (1) | IL258397A (https=) |
| MA (1) | MA42979A (https=) |
| MX (1) | MX2018004545A (https=) |
| RU (1) | RU2766209C2 (https=) |
| WO (1) | WO2017065837A1 (https=) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2553225C2 (ru) | 2008-05-23 | 2015-06-10 | Сива Корпорейшн | Способ облегчения регенерации |
| ES2725852T3 (es) | 2010-09-27 | 2019-09-27 | Siwa Corp | Eliminación selectiva de células modificadas por AGE para el tratamiento de la aterosclerosis |
| US8721571B2 (en) | 2010-11-22 | 2014-05-13 | Siwa Corporation | Selective removal of cells having accumulated agents |
| EP3194439B1 (en) | 2014-09-19 | 2022-01-19 | Siwa Corporation | Anti-age antibodies for treating inflammation and auto-immune disorders |
| US9993535B2 (en) | 2014-12-18 | 2018-06-12 | Siwa Corporation | Method and composition for treating sarcopenia |
| US10358502B2 (en) | 2014-12-18 | 2019-07-23 | Siwa Corporation | Product and method for treating sarcopenia |
| US10889634B2 (en) | 2015-10-13 | 2021-01-12 | Siwa Corporation | Anti-age antibodies and methods of use thereof |
| HUE058854T2 (hu) * | 2016-02-19 | 2022-09-28 | Siwa Corp | Módszer és készítmény a rák kezelésére, az áttétes rákos sejtek elpusztítására és a rák áttétképzõdésének megelõzésére a fejlett glikációs végtermékek (AGE) elleni antitest alkalmazásával |
| KR20180133452A (ko) | 2016-04-15 | 2018-12-14 | 시와 코퍼레이션 | 신경퇴행성 질환을 치료하기 위한 항-노화 항체 |
| JP2019518763A (ja) | 2016-06-23 | 2019-07-04 | シワ コーポレーション | 様々な疾患及び障害の治療において使用するためのワクチン |
| US10858449B1 (en) | 2017-01-06 | 2020-12-08 | Siwa Corporation | Methods and compositions for treating osteoarthritis |
| US10961321B1 (en) | 2017-01-06 | 2021-03-30 | Siwa Corporation | Methods and compositions for treating pain associated with inflammation |
| US10925937B1 (en) | 2017-01-06 | 2021-02-23 | Siwa Corporation | Vaccines for use in treating juvenile disorders associated with inflammation |
| US10995151B1 (en) | 2017-01-06 | 2021-05-04 | Siwa Corporation | Methods and compositions for treating disease-related cachexia |
| CA3059803A1 (en) | 2017-04-13 | 2018-10-18 | Siwa Corporation | Humanized monoclonal advanced glycation end-product antibody |
| US20200150131A1 (en) * | 2017-05-04 | 2020-05-14 | Siwa Corporation | Diagnostic advanced glycation end-product antibodies |
| JP6994876B2 (ja) * | 2017-09-05 | 2022-01-14 | 株式会社エッグ | 計測器 |
| US11518801B1 (en) | 2017-12-22 | 2022-12-06 | Siwa Corporation | Methods and compositions for treating diabetes and diabetic complications |
| WO2019183282A1 (en) * | 2018-03-21 | 2019-09-26 | Mayo Foundation For Medical Education And Research | Senolytic agents for the treatment of tauopathies |
| EP3826670A1 (en) * | 2018-07-23 | 2021-06-02 | Siwa Corporation | Methods and compositions for treating chronic effects of radiation and chemical exposure |
| WO2020041625A1 (en) * | 2018-08-23 | 2020-02-27 | Siwa Corporation | Anti carboxymethyl lysine antibodies and ultrasound for removing age-modified cells |
| US20230181730A1 (en) * | 2020-05-01 | 2023-06-15 | Siwa Corporation | Methods of treating infections |
| CN120757653A (zh) * | 2021-07-13 | 2025-10-10 | 迈威(美国)生物治疗有限公司 | 抗c1s抗体和其用途 |
| CN114031687B (zh) * | 2021-11-12 | 2022-06-07 | 深圳市人民医院 | 靶向rage的纳米抗体及其应用 |
| WO2023177390A1 (en) * | 2022-03-14 | 2023-09-21 | Siwa Corporation | Humanized monoclonal advanced glycation end-product antibody for treating pancreatic cancer |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4217344A (en) | 1976-06-23 | 1980-08-12 | L'oreal | Compositions containing aqueous dispersions of lipid spheres |
| US4911928A (en) | 1987-03-13 | 1990-03-27 | Micro-Pak, Inc. | Paucilamellar lipid vesicles |
| US4917951A (en) | 1987-07-28 | 1990-04-17 | Micro-Pak, Inc. | Lipid vesicles formed of surfactants and steroids |
| US5624804A (en) * | 1991-12-20 | 1997-04-29 | The Rockefeller University | Immunochemical detection of In vivo advanced glycosylation end products |
| US6387373B1 (en) | 1993-01-15 | 2002-05-14 | Novavax, Inc. | Vaccines containing paucilsmellar lipid vesicles as immunological adjuvants |
| US6380165B1 (en) | 1997-09-19 | 2002-04-30 | The Picower Institute For Medical Research | Immunological advanced glycation endproduct crosslink |
| CN100340575C (zh) * | 1999-06-25 | 2007-10-03 | 杰南技术公司 | 人源化抗ErbB2抗体及其在制备药物中的应用 |
| JP4012722B2 (ja) * | 2001-11-22 | 2007-11-21 | 株式会社トランスジェニック | カルボキシメチル化ペプチドに対する抗体 |
| EP1988918A4 (en) | 2006-02-22 | 2010-04-28 | Novavax Inc | ADJUVANZ AND VACCINE COMPOSITIONS |
| RU2553225C2 (ru) | 2008-05-23 | 2015-06-10 | Сива Корпорейшн | Способ облегчения регенерации |
-
2016
- 2016-05-27 CN CN201680059997.5A patent/CN108431044A/zh active Pending
- 2016-05-27 RU RU2018110885A patent/RU2766209C2/ru active
- 2016-05-27 KR KR1020187010762A patent/KR20180056689A/ko not_active Abandoned
- 2016-05-27 MX MX2018004545A patent/MX2018004545A/es unknown
- 2016-05-27 JP JP2018519727A patent/JP2018535953A/ja active Pending
- 2016-05-27 WO PCT/US2016/034880 patent/WO2017065837A1/en not_active Ceased
- 2016-05-27 MA MA042979A patent/MA42979A/fr unknown
- 2016-05-27 AU AU2016336959A patent/AU2016336959A1/en not_active Abandoned
- 2016-05-27 BR BR112018007422A patent/BR112018007422A2/pt not_active Application Discontinuation
- 2016-05-27 CA CA3000815A patent/CA3000815C/en active Active
- 2016-05-27 EP EP16731696.7A patent/EP3362483A1/en not_active Withdrawn
-
2018
- 2018-03-27 IL IL258397A patent/IL258397A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018535953A5 (https=) | ||
| RU2018110885A (ru) | Антитела к age и способы их применения | |
| Chatterjee et al. | Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson’s disease model | |
| AU2021202095B9 (en) | Use of semaphorin-4D binding molecules for treating neurodegenerative disorders | |
| Torres-Espín et al. | Eliciting inflammation enables successful rehabilitative training in chronic spinal cord injury | |
| JP5730464B2 (ja) | 延長効果をもつ新規鎮痛治療 | |
| RU2018132998A (ru) | Способ и композиция для лечения рака, уничтожения метастатических раковых клеток и профилактики метастазов рака, используя антитела к конечным продуктам повышенного гликирования ( AGE) | |
| Pekna et al. | Modulation of neural plasticity as a basis for stroke rehabilitation | |
| JP2017529363A5 (https=) | ||
| JP5419448B2 (ja) | 疼痛に対するオピオイド鎮痛薬効果の増強のための方法 | |
| JP2021532114A5 (https=) | ||
| JP2014518615A5 (https=) | ||
| JP2017536111A5 (https=) | ||
| JP2021532114A (ja) | 放射線曝露及び化学物質曝露の慢性影響を治療するための方法及び組成物 | |
| JP2017532952A5 (https=) | ||
| JP2009544279A5 (https=) | ||
| AR084210A1 (es) | PROTEINAS DE UNION AL TNF-a | |
| AR038953A1 (es) | Anticuerpos humanizados que reconocen el peptido amiloide beta | |
| EA200970694A1 (ru) | ПЭГИЛИРОВАННЫЕ Fab-ФРАГМЕНТЫ АНТИТЕЛ К ПЕПТИДУ Aβ | |
| Tysseling et al. | SDF1 in the dorsal corticospinal tract promotes CXCR4+ cell migration after spinal cord injury | |
| JP2014510519A5 (https=) | ||
| JP2017529870A5 (https=) | ||
| JP2015520608A5 (https=) | ||
| Dalise et al. | Adaptive plasticity and recovery in preclinical models of stroke | |
| RU2020104587A (ru) | Потенцирование компонентами крови антибактериальной активности литических белков, соответствующие способы и применения |